» Articles » PMID: 2311294

The Level of Mannan-binding Protein Regulates the Binding of Complement-derived Opsonins to Mannan and Zymosan at Low Serum Concentrations

Overview
Date 1990 Feb 1
PMID 2311294
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

When sera diluted to 5% in a buffer containing calcium and magnesium were incubated with mannan-coated ELISA plates, C4 fragments, properdin and factor B were bound to the plates as well as the expected opsonic C3 fragments, C3b and C3bi. The calcium-dependent lectin mannan-binding protein, which is structurally similar to C1q, was also shown to bind in this assay and analysis of sera from 179 healthy blood donors revealed that the binding levels of all these proteins were highly significantly correlated. Results obtained with a previously described C3b opsonic assay using zymosan also correlated with the mannan-binding levels. When the sera were diluted to 5% in the presence of Mg-EGTA there was no detectable binding of complement proteins to the mannan surface, confirming that no alternative pathway activation occurred at this serum concentration. When sera were diluted to 5% in a buffer containing EDTA in order to study immunoglobulin binding in the absence of complement activation, the levels of bound IgG1, IgG2, IgG3, IgA and IgM antibodies were found to be completely unrelated to the C3bi binding levels previously observed. The results suggest that in this experimental system using low concentrations of serum, mannan-binding protein initiates an antibody-independent mechanism of cleavage of the classical pathway component C4, which subsequently regulates the degree of cleavage of C3 and recruitment of alternative pathway proteins.

Citing Articles

Multivalent, calcium-independent binding of surfactant protein A and D to sulfated glycosaminoglycans of the alveolar epithelial glycocalyx.

Avcibas R, Vermul A, Gluhovic V, Boback N, Arroyo R, Kingma P Am J Physiol Lung Cell Mol Physiol. 2024; 326(5):L524-L538.

PMID: 38375572 PMC: 11380953. DOI: 10.1152/ajplung.00283.2023.


Distinction of early complement classical and lectin pathway activation quantification of C1s/C1-INH and MASP-1/C1-INH complexes using novel ELISAs.

Hurler L, Toonen E, Kajdacsi E, van Bree B, Brandwijk R, de Bruin W Front Immunol. 2022; 13:1039765.

PMID: 36420270 PMC: 9677118. DOI: 10.3389/fimmu.2022.1039765.


Evaluation of Mannose Binding Lectin Gene Variants in Pediatric Influenza Virus-Related Critical Illness.

Levy E, Yip W, Super M, Ferdinands J, Mistry A, Newhams M Front Immunol. 2019; 10:1005.

PMID: 31139182 PMC: 6518443. DOI: 10.3389/fimmu.2019.01005.


Ficolin-2 defends against virulent Mycobacteria tuberculosis infection in vivo, and its insufficiency is associated with infection in humans.

Luo F, Sun X, Wang Y, Wang Q, Wu Y, Pan Q PLoS One. 2013; 8(9):e73859.

PMID: 24040095 PMC: 3767610. DOI: 10.1371/journal.pone.0073859.


Fluorochrome-linked immunoassay for functional analysis of the mannose binding lectin complement pathway to the level of C3 cleavage.

Walsh M, Shaffer L, Guikema B, Body S, Shernan S, Fox A J Immunol Methods. 2007; 323(2):147-59.

PMID: 17512534 PMC: 1976379. DOI: 10.1016/j.jim.2007.04.004.


References
1.
Bacon J, FARMER V, Jones D, TAYLOR I . The glucan components of the cell wall of baker's yeast (Saccharomyces cerevisiae) considered in relation to its ultrastructure. Biochem J. 1969; 114(3):557-67. PMC: 1184928. DOI: 10.1042/bj1140557. View

2.
Phaff H . CELL WALL OF YEASTS. Annu Rev Microbiol. 1963; 17:15-30. DOI: 10.1146/annurev.mi.17.100163.000311. View

3.
Levinsky R, Harvey B, Paleja S . A rapid objective method for measuring the yeast opsonisation activity of serum. J Immunol Methods. 1978; 24(3-4):251-6. DOI: 10.1016/0022-1759(78)90129-1. View

4.
Guesdon J, Ternynck T, Avrameas S . The use of avidin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem. 1979; 27(8):1131-9. DOI: 10.1177/27.8.90074. View

5.
Roberton D, Dhanjal N, Levinsky R, Mowbray J, Turner M . Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization. Clin Exp Immunol. 1981; 43(1):208-14. PMC: 1537125. View